[1]
E. Zalyubovskaya, “LIPID HOMEOSTASIS PECULARITIES IN ISCHEMIC HEART DISEASE PATIENTS WITH HEART FAILURE SYMPTOMS, DIABETES MELLITUS 2 TYPE AND METABOLIC SYNDROME DEPENDING ON MEDICATION PECULIARITIES”, J. V. N. Karazin Khark. Nat. Univ., Ser. Med., no. 15, pp. 79-84, 1.